When your prescription runs out and the pharmacy says they can’t get more, it’s not just an inconvenience-it’s a health risk. In 2025, over 200 essential drugs remained in short supply across the U.S. and Europe, including antibiotics like ampicillin, chemotherapy agents like vincristine, and even basic IV fluids. These aren’t rare or niche medications-they’re the backbone of everyday care. And while manufacturers blame raw material delays, regulatory hurdles, and global supply chain fragility, health systems are stepping in to fill the gap. Here’s what they’re actually doing right now.
Building smarter inventory systems
Forget the old model of stocking shelves until they’re empty. Leading hospitals now use real-time inventory tracking powered by AI. Baptist Health in Florida, for example, installed smart shelves that automatically log when a vial is taken and alert pharmacists when stock falls below a 14-day threshold. This isn’t just about avoiding empty shelves-it’s about predicting shortages before they happen. Their system cross-references national shortage alerts from the FDA and supplier lead times, then auto-generates purchase orders. The result? A 41% drop in critical drug stockouts in 2024.
Smaller clinics can’t afford custom tech, but many are using free tools like the ASHP Drug Shortage Resource Center, which offers real-time dashboards updated daily. One community pharmacy in Birmingham started using it to prioritize orders. Instead of waiting for suppliers to call, they now check the dashboard every morning and place orders for high-risk items before the weekend. Simple. Effective.
Switching to alternative formulations
When a drug is unavailable, clinicians don’t just wait. They swap. But not randomly. Health systems now have formalized substitution protocols approved by pharmacy and therapeutics committees. For example, when the brand-name version of levothyroxine was in short supply, hospitals switched to FDA-approved generics-many of which are chemically identical but cheaper and more available. In 2024, over 60% of U.S. hospitals adopted similar protocols for at least five high-demand drugs.
Some switches require more nuance. When injectable epinephrine ran low, some ERs started using auto-injectors with lower concentrations and adjusted dosing based on patient weight. These aren’t off-label hacks-they’re evidence-based changes tested in pilot programs and published in peer-reviewed journals. The key? Documentation. Every substitution is logged in the electronic health record so future providers know what was used and why.
Collaborating across hospitals
One hospital can’t solve a shortage alone. But a network can. Regional drug-sharing networks are growing fast. In the Midwest, 14 hospitals formed a cooperative called the Heartland Medication Alliance. When one facility runs out of a critical antibiotic, they ping the network. Another hospital with surplus stock ships it overnight via courier-no paperwork, no billing. It’s all tracked through a shared portal. Since launching in 2023, they’ve redistributed over 12,000 doses of shortage-affected drugs.
Similar networks exist in the UK, where NHS trusts in the West Midlands share inventory through the Regional Pharmacy Hub. They don’t just move pills-they move expertise. Pharmacists from larger hospitals train smaller ones on how to stretch supplies safely, like using dilution protocols for pediatric doses when vials are too large.
Working with manufacturers to prioritize
Health systems aren’t just passive buyers anymore. They’re negotiating directly with manufacturers. In 2024, a coalition of 22 U.S. academic medical centers formed the Critical Medications Consortium. They pooled their purchasing power to guarantee supply of 12 high-risk drugs. In exchange for multi-year contracts, manufacturers agreed to reserve a fixed percentage of production for consortium members-even during global shortages.
They also started publishing transparency reports. When a supplier delays a shipment, the consortium publicly names the drug, the reason, and the expected date. That pressure works. One manufacturer, after being named in a report for a 6-week delay on sodium bicarbonate, sped up production and shipped ahead of schedule.
Training staff to stretch supplies
When you can’t get the drug, you make the most of what you have. Nurses and pharmacists are now trained in advanced compounding and dilution techniques. For example, when the supply of fentanyl for pain control dropped, some ICUs began using lower-dose vials and diluting them with sterile saline to create multiple doses from one vial. This requires strict protocols-each diluted dose is labeled with the exact concentration, date, time, and initials of the pharmacist who prepared it.
Training isn’t optional anymore. The American Society of Health-System Pharmacists now requires all hospital pharmacists to complete a 4-hour module on shortage management as part of continuing education. Hospitals that don’t comply risk losing accreditation.
Using AI to forecast and redirect
Generative AI is no longer science fiction in pharmacy departments. At Intermountain Healthcare, an AI model analyzes historical usage, seasonal trends, weather patterns (which affect patient volume), and supplier delivery times to predict shortages up to 90 days in advance. The system flagged a coming shortage of propofol three months before the FDA alert. They responded by shifting elective surgeries to other facilities, stockpiling alternative sedatives, and alerting anesthesiologists early.
Another tool, developed by a startup in Boston, scans news feeds, regulatory filings, and supplier announcements to detect early warning signs-like a plant closure in India that produces 70% of the world’s raw material for metformin. Health systems that use this tool now get alerts before the shortage hits headlines.
Shifting care models to reduce demand
One way to fight a shortage? Don’t need the drug as much. That’s the logic behind care redesign. At Kaiser Permanente, they reduced hospital admissions for chronic heart failure by 28% using remote monitoring. Patients wear a smart scale and blood pressure cuff that sends data to a nurse daily. If numbers dip, they get a call-no ER visit needed. Fewer admissions mean fewer diuretics, IV fluids, and antibiotics used.
Same with antibiotics. Some clinics now delay prescribing until a rapid test confirms a bacterial infection. In the past, doctors gave antibiotics “just in case.” Now, with faster point-of-care tests, they wait 24 hours. That small delay cuts antibiotic use by 19% annually.
What’s still broken
Not everything is fixed. Rural hospitals still struggle. One clinic in Alabama reported going 11 days without a critical anticoagulant because their supplier only ships to major distribution centers. And while big systems can afford AI and dedicated pharmacists, small pharmacies can’t. The gap is widening.
Also, some shortages are caused by profit-driven decisions. When a drug becomes generic and cheap, manufacturers stop making it. The market doesn’t reward volume-it rewards margin. So the most essential drugs-the ones that cost pennies-are the ones that vanish first.
Health systems are doing more than ever. But without policy changes-like incentives to keep low-margin essential drugs in production-these workarounds will keep playing whack-a-mole.
What patients can do
If you’re on a medication that’s been on shortage lists, talk to your pharmacist. Ask: Is there a generic? Can we switch brands? Do you know if another pharmacy nearby has it? Many pharmacies now have apps that show real-time stock status across locations.
Don’t wait until your last pill is gone. Call ahead. Keep a 7-day backup if possible. And if your doctor suggests a change, ask why-and if it’s safe. You’re not just a patient. You’re part of the solution.
7 Comments